Reliable Hypertension Diagnosis Based on 24 ABPM
How to Reliably Diagnose Arterial Hypertension: Lessons From 24h Blood Pressure Monitoring.
1 other identifier
observational
408
1 country
1
Brief Summary
24 h blood pressure monitoring can help to define which is the optimal timing and frequency of measurements
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedFirst Submitted
Initial submission to the registry
September 14, 2018
CompletedFirst Posted
Study publicly available on registry
September 18, 2018
CompletedSeptember 18, 2018
September 1, 2018
2 years
September 14, 2018
September 14, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Timing of measurement
9:00-13:00 - 13:00-17:00 - 17:00 - 21:00: there intervals were analyzed to assess the predictive value of each interval compared with the overall daytime diagnosis of hypertension.
day 1
Secondary Outcomes (1)
The correct number of measurements
day 1
Study Arms (1)
persons with arterial hypertension
patients referred to consultation cardiology for hypertension. They get a 24 h blood pressure monitoring to define the exact mean arterial blood pressure
Interventions
24 h ambulatory blood pressure measurements : an ambulatory 24 h blood pressure device that automatically measures blood pressure every 15 minutes is given to the patient for 24 h
Eligibility Criteria
Arterial hypertension, HBPM, 24h ABPM, optimal diagnosis
You may qualify if:
- per cent of valid measurements
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hasselt Universitylead
- Jessa Hospitalcollaborator
Study Sites (1)
Jessa Ziekenhuis
Hasselt, 3500, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Caro Brenard, student
University of Leuven
- STUDY CHAIR
Vincent Raymaekers, student
Universiteit Antwerpen
- PRINCIPAL INVESTIGATOR
Paul Dendale, prof. dr.
Hasselt University
- STUDY DIRECTOR
Ines Frederix, dr. MD
Hasselt University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 14, 2018
First Posted
September 18, 2018
Study Start
July 1, 2015
Primary Completion
July 1, 2017
Study Completion
July 1, 2017
Last Updated
September 18, 2018
Record last verified: 2018-09